Clinical Trials Directory

Trials / Conditions / Relapsed Solid Tumors

Relapsed Solid Tumors

8 registered clinical trials studyying Relapsed Solid Tumors — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingPEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
NCT06721689
Theodore LaetschPhase 1 / Phase 2
RecruitingPersonalized KSX01-TCRT in Patients With Advanced Solid Tumors
NCT06150365
Cancer Institute and Hospital, Chinese Academy of Medical SciencesEARLY_Phase 1
RecruitingKSX01-TCRT Injection Project in Solid Tumors
NCT05811975
TCRx Therapeutics Co.LtdEARLY_Phase 1
RecruitingKSH01-TCRT Solid Tumors
NCT05539833
TCRx Therapeutics Co.LtdEARLY_Phase 1
TerminatedA Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High
NCT04718675
Kronos BioPhase 1 / Phase 2
CompletedCarfilzomib in Combination With Cyclophosphamide and Etoposide for Children
NCT02512926
Stanford UniversityPhase 1
CompletedA Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed
NCT02596503
University of Colorado, DenverPhase 1
CompletedPharmacokinetic Studies Participation Survey
NCT00923468
National Cancer Institute (NCI)—